Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |